MassChallenge's Life Science Portfolio

iSpecimen is the marketplace for human biospecimens, providing researchers with the samples they need from the patients they want.

Folia Health is a platform that captures and shares secure health and symptom data for users.

Yeastime's value proposition is its innovative retrofitting ultrasound technology, which accelerates fermentation by up to 30%.

Annaida Technologies has developed a groundbreaking device, EmbryoSpin, that performs microscopic Nuclear Magnetic Resonance.

Gelatex has invented fast and scalable solution-spinning technology to produce nanofibers for various industries.

Enzymit is a bioproduction platform company based on computational protein design and ‘cell-free' enzymatic manufacturing technology

LIfT Biosciences® a rapidly emerging biotech company bringing to market a first-in-class allogeneic innate cell therapy

TissueLabs is a biotechnology research company that operates a platform for creating organs and tissues in the lab.

Symphony Biosciences is a biotech company that develops cancer drugs to help treat solid tumors.

Rqmicro develops a pathogen separation and detection technology that delivers accurate results in less than 2 hours.

Advanced Scanners provide optimal 3D surface mapping for precise intra-operative diagnostics and positioning.

Opsin Biotherapeutics develops a pipeline of opsin-based gene therapies for pain management

Reveal Pharmaceuticals is the gadolinium free MRI contrast agent.

Vectech's AI diagnostic entomology system identifies damaging insects that spread disease and cause agricultural or economic loss.

Stemloop—The Biosensor Company™—discovers, develops, and deploys cell-free biosensors to address unmet chemical sensing and detection needs.

We engineered the first injectable biomaterial that stimulated the body's natural ossification process for rapid bone repair & strengthening

Syntr Health Technologies develops and tests a processing device for the micro fragmentation of adipose tissue for body contouring.

React4life Srl is an Italian biotech company producing MIVO® (Multi In Vitro Organ), the next generation of organ-on-a-chip.